July 14-18, Los Angeles, California
Scientific Sessions
On This Page:
To search a full listing of sessions available at this year’s conference, use the AAIC Interactive Program Guide.
10:30 - 11:15 a.m.
Association Welcome
11:15 - 11:45 a.m.
Understanding the Earliest Phases of Alzheimer’s Disease
Johns Hopkins University School of Medicine, USA
Theme: Therapeutics
Session: PL-01-02
10:30 - 11 a.m.
Sleep, Brain and Cognition
University of California, Irvine, USA
Theme: Therapeutics
Session: PL-02-01
11 - 11:30 a.m.
Alzheimer’s Disease Blood-Based Biomarkers and AD Control
Seoul National University, South Korea
Theme: Diagnosis and Prognosis
Session: PL-02-02
10:30 - 11 a.m.
Inge Grundke-Iqbal Award for Alzheimer’s Research: Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia
NYU School of Medicine, USA
Theme: Basic and Translational Science
Session: PL-03-01
11 - 11:30 a.m.
The Epidemiology of Diversity and Dementia
University of California, Davis, USA
Theme: Public Health and Psychosocial
Session: PL-03-02
10:30 - 11 a.m.
Imaging Neurodegeneration With MRI: What Is New?
University of Pennsylvania Memory Center, USA
Theme: Diagnosis and Prognosis
Session: PL-04-01
11 - 11:30 a.m.
The Cellular Phase of Alzheimer’s Disease
University College London, United Kingdom; University of Leuven, Belgium
Theme: Basic and Translational Science
Session: PL-04-02
10:30 - 11 a.m.
Microglia in Neurodegenerative Conditions
Washington University in St. Louis, USA
Theme: Basic and Translational Science
Session: PL-05-01
11 - 11:30 a.m.
Precision Medicine, Population Neuroscience and Comprehensive Care: Partners to Develop and Deliver Effective Prevention and Treatments for Dementia
The University of Texas Health Science Center at San Antonio, USA
Theme: Public Health & Psychosocial
Session: PL-05-02
Symposium Sessions
-
Disparities in Access to Dementia Care and Prevention [S1-01]
8 - 9:30 a.m.
Theme: Public Health and Psychosocial
PRESENTATIONS
SPEAKERS
Dementia Prevention Programs in Urban and Regional Aboriginal Communities in Australia [S1-01-01]
Kylie Radford
University of New South Wales, Australia
Effects of Health Literacy on Access to Dementia Care [S1-01-02]
Jennifer Lingler
University of Pittsburgh, USA
Improving the Lives of People with Dementia - The OECD Perspective [S1-01-03]
Elina Suzuki
Organization for Economic Co-operation and Development, France
Dementia As Access Barrier in Palliative Care [S1-01-04]
Jenny T. van der Steen
Leiden University Medical Center, Leiden, Netherlands
-
“Rare Variants” And Their Role In Genetic Etiology And Disease [S1-02]
8 - 9:30 a.m.
Theme: Basic and Translational Science
PRESENTATIONS
SPEAKERS
Clustering of Rare Variants in Alzheimer Disease and Related Disorders in the Colombian Population: A Genomic Study [S1-02-01]
Ken Kosik
University of California, USA
The Potential Contribution of Rare Variants to Neurodegenerative Brain Dementia [S1-02-02]
Gary Beecham
The Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine, USA
Whole-Exome Sequencing in 20,197 Persons for Rare Variants in Alzheimer's Disease [S1-02-03]
Richard Mayeux
Columbia University Medical Center, USA
High-Throughput Identification of Noncoding Functional SNPs [S1-02-04]
Gang Li
University of Pittsburgh School of Medicine, USA
-
PET and CSF Markers of Neuroinflammation [S2-01]
8 - 9:30 a.m.
Theme: Diagnosis and Prognosis
PRESENTATIONS
SPEAKERS
PET Markers of Microglia [S2-01-01]
Robert Innis
National Institute of Mental Health, USA
PET Markers of Astrocytes [S2-01-02]
Elena Rodriguez-Vieitez
Karolinska Institute, Sweden
Neuroinflammation: CSF Perspective [S2-01-03]
Shorena Janelidze
Lund University, Sweden
Fluid Biomarkers of Neuroinflammation [S2-01-04]
Charlotte Teunissen
VU University Medical Center, Netherlands
-
Precision Medicine [S2-02]
8 - 9:30 a.m.
Theme: Therapeutics
PRESENTATIONS
SPEAKERS
Precision Medicine Model for Targeted NSAID Therapy in AD [S2-02-01]
Sid O'Bryant
University of North Texas Health Science Center, USA
PPAR-Gamma [S2-02-02]
Michael Heneka
German Center for Neurodegenerative Diseases (DZNE), Germany
Insulin-Resistant Sub-Typing [S2-02-03]
Suzanne Craft
Wake Forest School of Medicine, USA
Subtyping of Clinical Subjects through Exosome Analyses [S2-02-04]
Dimitrios Kapogiannis
National Institute on Aging/National Institutes of Health (NIA/NIH), USA
-
Overlapping AD Pathologies and their Influence on Disease Phenotypes [S3-01]
8 - 9:30 a.m.
Theme: Diagnosis and Prognosis
PRESENTATIONS
SPEAKERS
Alzheimer’s and Vascular Disease: Pathologic Perspective [S3-01-01]
Costantino Iadecola
Weill Cornell Medicine, USA
Alzheimer’s Disease and Subcortical Vascular Cognitive Impairment (SVCI): Biomarker Perspective [S3-01-02]
Duk Na
Samsung Medical Center; Sungkyunkwan University School of Medicine, Korea, Republic of Korea (South)
Alzheimer’s and Lewy Body Disease: Pathologic Perspective [S3-01-03]
David Irwin
University of Pennsylvania, USA
Alzheimer’s and Lewy Body Disease: Biomarker Perspective [S3-01-04]
Evelien Lemstra
Amsterdam University Medical Centers, Netherlands
-
Responder Analyses Leading to Hypothesis Generation for Prospective Study Designs [S3-02]
8 - 9:30 a.m.
Theme: Therapeutics
PRESENTATIONS
SPEAKERS
Statistical Challenges With Responder Analysis in Exploratory Settings [S3-02-01]
Suzanne Hendrix
Pentara Corporation, USA
Multi-Crossover Randomized Control Design Approaches Based on Analyses of Responder/Non-Responder Outcomes [S3-02-02]
Steven Arnold Massachusetts General Hospital, USA; Harvard Medical School, USA
To be announced.
Statistical Considerations for Efficient Designs within a Platform Trial Approach [S3-02-03]
Karen Messer
University of California San Diego, USA
Determining Whether Identification of a Responder Sub-Group Is Truly Hypothesis Generating [S3-02-04]
Eric Siemers
Cogstate, Ltd., USA
-
National Dementia Registries: Quality Control and Recruitment of Research Participants [S4-01]
8 - 9:30 a.m.
Theme: Public Health and Psychosocial
PRESENTATIONS
SPEAKERS
The Brain Health Registry for Recruitment of Research Participants: 5 Year Experience [S4-01-01]
Michael Weiner
University of California, San Francisco, USA
The Dutch Brain Health Registry for Recruitment of Research Participants [S4-01-02]
Marissa Zwan
VU University Medical Center, Netherlands
Swedish Clinical Quality Registry for Dementia [S4-01-03]
Dorota Religa
Karolinska Institute, Sweden
Australian Clinical Quality Registry for Dementia [S4-01-04]
Stephanie Ward
Monash University, Australia
-
Delirium in Dementia: A Translational Aspect [S5-01]
8:30 - 10 a.m.
Theme: Basic and Translational Science
PRESENTATIONS
SPEAKERS
Description and Impact of Delirium on Dementia [S5-01-01]
Daniel Davis
University College London, United Kingdom
Biomarkers in Delirium [S5-01-02]
Gideon Caplan
University of New South Wales, Australia
Neurobiology of Delirium and Its Intersection with Dementia: Insights from Animal Models [S5-01-03]
Colm Cunningham
Trinity College Dublin, Ireland
Systemic Inflammation Signaling to the Brain [S5-01-04]
Roosmarijn Vandenbroucke
Ghent University, Belgium
Become an ISTAART Member
Members of this professional society stay connected to the field through exclusive member benefits and programs. Join for just $30* at the Alzheimer's Association (Booth 500).
*Offer available onsite at AAIC (through 7/18/19). Applies only to registrants who paid the non-member fee.
Preconferences & Educational Workshops
Learn the basics or brush up on your skills by attending an AAIC preconference or educational workshop. These events provide the opportunity to explore the newest findings and practices for the prevention and treatment of Alzheimer's disease and other dementias.
lg > 992px
md > 768px
sm < 767px
xs
Join the Conversation #AAIC19